Sg3 Management, LLC Omeros Corp Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $9,648 - $13,701	-1,903 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$5.67 - $8.54 $388,944 - $585,818	-68,597 Reduced 97.3%	1,903 $12,000
Q2 2021 Aug 16, 2021	SELL	$14.81 - $19.13 $1.03 Million - $1.33 Million	-69,500 Reduced 49.64%	70,500 $1.05 Million
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $1.45 Million - $2.35 Million	100,000 Added 250.0%	140,000 $2.49 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $21.32 $382,800 - $852,800	40,000 New	40,000 $404,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.